7/24/2026 6:48:37 PM The Reemergence of SPACs By Michael Levitt Jeremy Barr More than 125 SPACs have completed IPOs in 2026, and privately held companies have renewed interest in deSPAC transactions. A number of...
7/24/2026 3:48:37 PM Federal Contracts for Biotech: Opportunities, With Strings Attached By Kristen Riemenschneider Jeff Jay Nathan Castellano The U.S. federal government is increasingly focused on the biotech and broader life sciences industry. This creates both risks and...
7/23/2026 7:42:38 PM Takeaways from the Freshfields Mexico City Forum By Ethan Klingsberg Noiana Marigo Timothy Howard Alessio Evangelista Stephanie Brown Cripps Paul Humphreys Christine Wilson Melissa Hodgman Erik Gerding +6 more... Show less Thank you to the more than 100 attendees who filled the room at the Freshfields Mexico City Forum. The event brought together Freshfields...
7/21/2026 1:54:07 PM Life Sciences Round Up – Q2 2026 By Kristen Riemenschneider Jeff Jay Juliana Zhang Q2 2026 brought no shortage of activity to the life sciences sector. Here are the top issues and trends we've been tracking. US/China...
6/24/2026 11:01:07 AM Trends and Updates from the 2026 Proxy Season By Elizabeth Bieber Pamela Marcogliese Abbey MacDonald Heather Brookfield Kathleen Emberger Sarah Ghulamhussain David Livshiz Jennifer Loeb Justin Stewart-Teitelbaum Sam Houshower +7 more... Show less The Freshfields team reviewed key trends and developments for the 2026 proxy season, summarizing takeaways and guidance across several...
6/16/2026 7:27:07 PM Governance That Holds: What Five Years of Sponsor-Backed IPOs Tell You By Jacqueline Marino Sarah Solum Pamela Marcogliese Neal Reenan Ian Bushner +2 more... Show less For private equity sponsors, the path to a public market listing involves a series of governance decisions that shape influence long...
6/15/2026 9:39:37 PM Sticking to the Schedule: What the SEC’s Proposed Rescission of its Climate-Related Disclosure Rules Signals for Future Disclosure Rulemaking Beyond Climate By Erik Gerding Melissa Hodgman Ginger Hervey On May 29, 2026, the U.S. Securities and Exchange Commission (the SEC, or the Commission) voted to propose the rescission of its March...
5/19/2026 9:33:07 PM Takeaways from the 12th Annual Spring Forum on M&A and the Boardroom By Ethan Klingsberg Thank you to the in-person attendees who once again filled the venue to capacity and to the hundreds who joined virtually at the 12th...
5/7/2026 2:27:07 PM Mixing Retail and Software: The FTC’s Blend of Structural and Behavioral Remedies in 365 Retail/Cantaloupe By Justin Stewart-Teitelbaum Kara Reid Eleanor Liu On May 1, 2026, the Federal Trade Commission (FTC) approved 365 Retail Markets’ approximately $848 million acquisition of Cantaloupe,...
4/24/2026 5:54:07 PM Unscrambling the Egg? What to Watch in the Nexstar/Tegna Merger Challenge By Julie Elmer Justin Stewart-Teitelbaum Ellen Rosenblum Tyler Garrett Kara Reid Amy Cheng +3 more... Show less On April 17th, Judge Troy Nunley of the Eastern District of California issued a preliminary injunction (PI) prohibiting the further...
4/17/2026 8:36:07 PM SEC Halves Tender Offer Period for Negotiated All-Cash Deals from 20 to 10 Business Days—A Potential Game-Changer for M&A Execution By Erik Gerding Melissa Hodgman Michael Levitt On April 16, 2026, the SEC’s Division of Corporation Finance (the “Division”), in a move intended to “address market inefficiencies,...
4/7/2026 5:49:54 PM Life Sciences Round Up - Q1 2026 By Kristen Riemenschneider Madeleine Tavcar The first quarter of 2026 has been anything but quiet in the life sciences sector. Here are the top issues and trends we’ve noticed in...
3/23/2026 9:35:08 PM State AGs as Independent Enforcers: What to Glean from the Challenge to the Nexstar/Tegna Acquisition By Julie Elmer Ellen Rosenblum Kara Reid Amy Cheng +1 more... Show less March brought a one‑two punch for Nexstar’s proposed $6.2 billion acquisition of Tegna. On March 18th, eight state attorneys...
3/16/2026 2:39:56 PM Distressed Financing Pitfalls: When Execution Goes Off Track (Part 5) By Samantha Braunstein We know you missed us, so we are back to examine some more pitfalls that may be unidentified or ignored until they are those monsters...
2/23/2026 4:20:36 PM SEC Adds Flexibility to M&A, Proxy, and Tender Offer Rules with New Interpretations – Not All of the Implications of Which Are Apparent on Their Face By Ethan Klingsberg Michael Levitt Elizabeth Bieber Jeremy Barr +1 more... Show less On January 23, 2026, the Securities and Exchange Commission’s Division of Corporation Finance (“CorpFin”) published new and revised...
2/13/2026 8:52:43 PM Key Drivers for the FTC’s First Merger Victory of the Second Trump Administration By Meghan Rissmiller Andrew Ewalt Julie Elmer Constance Forkner Sam Fulliton Chris Kraft Kara Reid Gabriella Small +5 more... Show less Edwards Lifesciences Corp. (Edwards) abandoned its $945 million acquisition of JenaValve Technology, Inc. (JenaValve) after the U.S....